{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:33:10Z","timestamp":1795066390434,"version":"4.10.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transient oligomeric species formed during the aggregation process of the 42-residue form of the amyloid-\u03b2 peptide (A\u03b2<jats:sub>42<\/jats:sub>) are key pathogenic agents in Alzheimer\u2019s disease (AD). To investigate the relationship between A\u03b2<jats:sub>42<\/jats:sub> aggregation and its cytotoxicity and the influence of a potential\u00a0drug on both phenomena, we have studied the effects of trodusquemine. This aminosterol enhances the rate of aggregation by promoting monomer-dependent secondary nucleation, but significantly reduces the toxicity of the resulting oligomers to neuroblastoma cells by inhibiting their binding to the cellular membranes. When administered to a <jats:italic>C. elegans<\/jats:italic> model of AD, we again observe an increase in aggregate formation alongside the suppression of A\u03b2<jats:sub>42<\/jats:sub>-induced toxicity. In addition to oligomer displacement, the reduced toxicity could also point towards an increased rate of conversion of oligomers to less toxic fibrils. The ability of a small molecule to reduce the toxicity of oligomeric species represents a potential therapeutic strategy against AD.<\/jats:p>","DOI":"10.1038\/s41467-018-07699-5","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T17:14:10Z","timestamp":1547054050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Trodusquemine enhances A\u03b242 aggregation but suppresses its toxicity by displacing oligomers from cell membranes"],"prefix":"10.1038","volume":"10","author":[{"given":"Ryan","family":"Limbocker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco S.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-8376","authenticated-orcid":false,"given":"Michele","family":"Perni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cascella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella T.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-7715","authenticated-orcid":false,"given":"Georg","family":"Meisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-7348","authenticated-orcid":false,"given":"Benedetta","family":"Mannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Habchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C. T.","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan K.","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-7334","authenticated-orcid":false,"given":"Minkoo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Casford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilumi","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine K.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina D.","family":"Kloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel I. A.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3887-4964","authenticated-orcid":false,"given":"Janet R.","family":"Kumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zasloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-7109","authenticated-orcid":false,"given":"Sara","family":"Linse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas P. J.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1289","authenticated-orcid":false,"given":"Fabrizio","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-1610","authenticated-orcid":false,"given":"Christopher M.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"7699_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"7699_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","volume":"15","author":"TPJ Knowles","year":"2014","unstructured":"Knowles, T. P. J., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 15, 384\u2013396 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7699_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper, B. & Karran, E. The cellular phase of Alzheimer\u2019s disease. Cell 164, 603\u2013615 (2016).","journal-title":"Cell"},{"key":"7699_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer\u2019s disease. Lancet 377, 1019\u20131031 (2011).","journal-title":"Lancet"},{"key":"7699_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"7699_CR6","first-page":"77sr1","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer\u2019s disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr1 (2011).","journal-title":"Sci. Transl. Med."},{"key":"7699_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7699_CR8","doi-asserted-by":"crossref","first-page":"e1501244","DOI":"10.1126\/sciadv.1501244","volume":"2","author":"J Habchi","year":"2016","unstructured":"Habchi, J. et al. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A\u03b242 aggregates linked with Alzheimer\u2019s disease. Sci. Adv. 2, e1501244 (2016).","journal-title":"Sci. Adv."},{"key":"7699_CR9","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1073\/pnas.1615613114","volume":"114","author":"J Habchi","year":"2017","unstructured":"Habchi, J. et al. Systematic development of small molecules to inhibit specific microscopic steps of A\u03b242 aggregation in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 114, E200\u2013E208 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.719","volume":"8","author":"J Bieschke","year":"2012","unstructured":"Bieschke, J. et al. Small-molecule conversion of toxic oligomers to nontoxic \u03b2-sheet\u2013rich amyloid fibrils. Nat. Chem. Biol. 8, 93\u2013101 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"7699_CR11","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl Acad. Sci. USA 107, 7710\u20137715 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR12","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M110.173856","volume":"286","author":"ARA Ladiwala","year":"2011","unstructured":"Ladiwala, A. R. A., Dordick, J. S. & Tessier, P. M. Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J. Biol. Chem. 286, 3209\u20133218 (2011).","journal-title":"J. Biol. Chem."},{"key":"7699_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings, J. L., Morstorf, T. & Zhong, K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther. 6, 37 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"7699_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tips.2013.12.005","volume":"35","author":"P Arosio","year":"2014","unstructured":"Arosio, P., Vendruscolo, M., Dobson, C. M. & Knowles, T. P. J. Chemical kinetics for drug discovery to combat protein aggregation diseases. Trends Pharmacol. Sci. 35, 127\u2013135 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"7699_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen, S. I. A. et al. A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers. Nat. Struct. Mol. Biol. 22, 207\u2013213 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"7699_CR16","doi-asserted-by":"crossref","unstructured":"Chia, S. SAR by kinetics for drug discovery in protein misfolding diseases. Proc. Natl Acad. Sci. USA\u00a0115, 10245\u201310250 (2018).","DOI":"10.1073\/pnas.1807884115"},{"key":"7699_CR17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"7699_CR18","doi-asserted-by":"crossref","first-page":"e1700488","DOI":"10.1126\/sciadv.1700488","volume":"3","author":"FA Aprile","year":"2017","unstructured":"Aprile, F. A. et al. Selective targeting of primary and secondary nucleation pathways in A\u03b242 aggregation using a rational antibody scanning method. Sci. Adv. 3, e1700488 (2017).","journal-title":"Sci. Adv."},{"key":"7699_CR19","doi-asserted-by":"crossref","first-page":"12479","DOI":"10.1073\/pnas.1117799109","volume":"109","author":"B Mannini","year":"2012","unstructured":"Mannini, B. et al. Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc. Natl Acad. Sci. USA 109, 12479\u201312484 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR20","doi-asserted-by":"crossref","unstructured":"Rao, M. et al. Aminosterols from the Dogfish Shark Squalus acanthias. J. Nat. Prod. 63, 631\u2013635 (2000).","DOI":"10.1021\/np990514f"},{"key":"7699_CR21","doi-asserted-by":"crossref","first-page":"15978","DOI":"10.1073\/pnas.1108558108","volume":"108","author":"M Zasloff","year":"2011","unstructured":"Zasloff, M. et al. Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc. Natl Acad. Sci. USA 108, 15978\u201315983 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR22","doi-asserted-by":"crossref","first-page":"E1009","DOI":"10.1073\/pnas.1616191114","volume":"114","author":"M Perni","year":"2017","unstructured":"Perni, M. et al. A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity. Proc. Natl. Acad. Sci. USA 114, E1009\u2013E1017 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7699_CR23","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1021\/acschembio.8b00466","volume":"13","author":"M Perni","year":"2018","unstructured":"Perni, M. et al. Multistep inhibition of \u03b1-synuclein aggregation and toxicity in vitro and in vivo by Trodusquemine. ACS Chem. Biol. 13, 2308\u20132319 (2018).","journal-title":"ACS Chem. Biol."},{"key":"7699_CR24","first-page":"2465","volume":"9","author":"D Hao","year":"2003","unstructured":"Hao, D. et al. A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. Clin. Cancer Res. 9, 2465\u20132471 (2003).","journal-title":"Clin. Cancer Res."},{"key":"7699_CR25","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/oby.2009.444","volume":"18","author":"KA Lantz","year":"2010","unstructured":"Lantz, K. A. et al. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity 18, 1516\u20131523 (2010).","journal-title":"Obesity"},{"key":"7699_CR26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.ijo.0801599","volume":"25","author":"M Zasloff","year":"2001","unstructured":"Zasloff, M. et al. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties. Int. J. Obes. Relat. Metab. Disord. 25, 689\u2013697 (2001).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"7699_CR27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/cn300170x","volume":"4","author":"J Luo","year":"2013","unstructured":"Luo, J. et al. Cellular polyamines promote amyloid-beta (A\u03b2) peptide fibrillation and modulate the aggregation pathways. ACS Chem. Neurosci. 4, 454\u2013462 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"7699_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/cn900015v","volume":"1","author":"E Hellstrand","year":"2009","unstructured":"Hellstrand, E., Boland, B., Walsh, D. M. & Linse, S. Amyloid \u03b2-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 1, 13\u201318 (2009).","journal-title":"ACS Chem. Neurosci."},{"key":"7699_CR29","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1021\/la501414j","volume":"30","author":"A Assarsson","year":"2014","unstructured":"Assarsson, A., Linse, S. & Cabaleiro-Lago, C. Effects of polyamino acids and polyelectrolytes on amyloid \u03b2 fibril formation. Langmuir 30, 8812\u20138818 (2014).","journal-title":"Langmuir"},{"key":"7699_CR30","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1529\/biophysj.104.049189","volume":"88","author":"D Dell\u2019Orco","year":"2005","unstructured":"Dell\u2019Orco, D., Xue, W. F., Thulin, E. & Linse, S. Electrostatic contributions to the kinetics and thermodynamics of protein assembly. Biophys. J. 88, 1991\u20132002 (2005).","journal-title":"Biophys. J."},{"key":"7699_CR31","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SIA Cohen","year":"2013","unstructured":"Cohen, S. I. A. et al. Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA 110, 9758\u20139763 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/ja408765u","volume":"136","author":"P Arosio","year":"2014","unstructured":"Arosio, P., Cukalevski, R., Frohm, B., Knowles, T. P. J. & Linse, S. Quantification of the concentration of A\u03b242 propagons during the lag phase by an amyloid chain reaction assay. J. Am. Chem. Soc. 136, 219\u2013225 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"7699_CR33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nprot.2016.010","volume":"11","author":"G Meisl","year":"2016","unstructured":"Meisl, G. et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat. Protoc. 11, 252\u2013272 (2016).","journal-title":"Nat. Protoc."},{"key":"7699_CR34","doi-asserted-by":"crossref","unstructured":"Michaels, T. C. T. et al. Chemical kinetics for bridging molecular mechanisms and macroscopic measurements of amyloid fibril formation. Annu. Rev. Phys. Chem.69, 273\u2013298\u00a0(2018).","DOI":"10.1146\/annurev-physchem-050317-021322"},{"key":"7699_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/srep31155","volume":"6","author":"FS Ruggeri","year":"2016","unstructured":"Ruggeri, F. S. et al. Nanoscale studies link amyloid maturity with polyglutamine diseases onset. Sci. Rep. 6, 31155 (2016).","journal-title":"Sci. Rep."},{"key":"7699_CR36","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.2174\/1381612822666160518141911","volume":"22","author":"FS Ruggeri","year":"2016","unstructured":"Ruggeri, F. S., Habchi, J., Cerreta, A. & Dietler, G. AFM-based single molecule techniques: unraveling the amyloid pathogenic species. Curr. Pharm. Des. 22, 3950\u20133970 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"7699_CR37","doi-asserted-by":"crossref","first-page":"065105","DOI":"10.1063\/1.3608916","volume":"135","author":"SIA Cohen","year":"2011","unstructured":"Cohen, S. I. A. et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J. Chem. Phys. 135, 065105 (2011).","journal-title":"J. Chem. Phys."},{"key":"7699_CR38","doi-asserted-by":"crossref","first-page":"15595","DOI":"10.1073\/pnas.1001740107","volume":"107","author":"A Sandberg","year":"2010","unstructured":"Sandberg, A. et al. Stabilization of neurotoxic Alzheimer amyloid-\u03b2 oligomers by protein engineering. Proc. Natl Acad. Sci. USA 107, 15595\u201315600 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan, G. et al. Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100, 330\u2013335 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7699_CR40","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Y Gong","year":"2003","unstructured":"Gong, Y. et al. Alzheimer\u2019s disease-affected brain: presence of oligomeric A\u03b2 ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100, 10417\u201310422 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","volume":"79","author":"MP Lambert","year":"2001","unstructured":"Lambert, M. P. et al. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595\u2013605 (2001).","journal-title":"J. Neurochem."},{"key":"7699_CR42","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR43","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FGD Felice","year":"2007","unstructured":"Felice, F. G. D. et al. A\u03b2 oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590\u201311601 (2007).","journal-title":"J. Biol. Chem."},{"key":"7699_CR44","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor, P. N. et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J. Neurosci. 27, 796\u2013807 (2007).","journal-title":"J. Neurosci."},{"key":"7699_CR45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2008.04.003","volume":"31","author":"PJ Shughrue","year":"2010","unstructured":"Shughrue, P. J. et al. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiol. Aging 31, 189\u2013202 (2010).","journal-title":"Neurobiol. Aging"},{"key":"7699_CR46","doi-asserted-by":"crossref","DOI":"10.1038\/srep32721","volume":"6","author":"E Evangelisti","year":"2016","unstructured":"Evangelisti, E. et al. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases. Sci. Rep. 6, 32721 (2016).","journal-title":"Sci. Rep."},{"key":"7699_CR47","doi-asserted-by":"crossref","unstructured":"Mannini, B. & Chiti, F. Chaperones as suppressors of protein misfolded oligomer toxicity. Front. Mol. Neurosci. 10, 98 (2017).","DOI":"10.3389\/fnmol.2017.00098"},{"key":"7699_CR48","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/cb500505m","volume":"9","author":"B Mannini","year":"2014","unstructured":"Mannini, B. et al. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem. Biol. 9, 2309\u20132317 (2014).","journal-title":"ACS Chem. Biol."},{"key":"7699_CR49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb1001203","volume":"5","author":"B Bolognesi","year":"2010","unstructured":"Bolognesi, B. et al. ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5, 735\u2013740 (2010).","journal-title":"ACS Chem. Biol."},{"key":"7699_CR50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","volume":"19","author":"F Bemporad","year":"2012","unstructured":"Bemporad, F. & Chiti, F. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem. Biol. 19, 315\u2013327 (2012).","journal-title":"Chem. Biol."},{"key":"7699_CR51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-2836(65)80111-5","volume":"13","author":"L Stryer","year":"1965","unstructured":"Stryer, L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin: a fluorescent probe of non-polar binding sites. J. Mol. Biol. 13, 482\u2013495 (1965).","journal-title":"J. Mol. Biol."},{"key":"7699_CR52","first-page":"E1994","volume":"112","author":"SW Chen","year":"2015","unstructured":"Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation. Proc. Natl Acad. Sci. USA 112, E1994\u2013E2003 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1326-7-57","volume":"7","author":"G McColl","year":"2012","unstructured":"McColl, G. et al. Utility of an improved model of amyloid-beta (A\u03b21-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer\u2019s disease. Mol. Neurodegener. 7, 57 (2012).","journal-title":"Mol. Neurodegener."},{"key":"7699_CR54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneumeth.2018.02.005","volume":"306","author":"M Perni","year":"2018","unstructured":"Perni, M. et al. Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery. J. Neurosci. Methods 306, 57\u201367 (2018).","journal-title":"J. Neurosci. Methods"},{"key":"7699_CR55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41536-017-0008-1","volume":"2","author":"AM Smith","year":"2017","unstructured":"Smith, A. M. et al. The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues. NPJ Regen. Med. 2, 4 (2017).","journal-title":"NPJ Regen. Med."},{"key":"7699_CR56","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1074\/jbc.M112.350124","volume":"287","author":"E Speretta","year":"2012","unstructured":"Speretta, E. et al. Expression in drosophila of tandem amyloid \u03b2 peptides provides insights into links between aggregation and neurotoxicity. J. Biol. Chem. 287, 20748\u201320754 (2012).","journal-title":"J. Biol. Chem."},{"key":"7699_CR57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507\u2013511 (2002).","journal-title":"Nature"},{"key":"7699_CR58","doi-asserted-by":"crossref","first-page":"11506","DOI":"10.1002\/anie.201706279","volume":"56","author":"S Dutta","year":"2017","unstructured":"Dutta, S. et al. Suppression of oligomer formation and formation of non-toxic fibrils upon addition of mirror-image A\u03b242 to the natural l-enantiomer. Angew. Chem. Int. Ed. Engl. 56, 11506\u201311510 (2017).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"7699_CR59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bpj.2010.11.041","volume":"100","author":"JD Schmit","year":"2011","unstructured":"Schmit, J. D., Ghosh, K. & Dill, K. What drives amyloid molecules to assemble into oligomers and fibrils? Biophys. J. 100, 450\u2013458 (2011).","journal-title":"Biophys. J."},{"key":"7699_CR60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2015.03.032","volume":"161","author":"DM Walther","year":"2015","unstructured":"Walther, D. M. et al. Widespread proteome remodeling and aggregation in aging C. elegans. Cell 161, 919\u2013932 (2015).","journal-title":"Cell"},{"key":"7699_CR61","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1096\/fj.15-281675","volume":"30","author":"L Moll","year":"2016","unstructured":"Moll, L., Ben-Gedalya, T., Reuveni, H. & Cohen, E. The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition. FASEB J. 30, 1656\u20131669 (2016).","journal-title":"FASEB J."},{"key":"7699_CR62","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jmb.2015.02.006","volume":"427","author":"SBM Miller","year":"2015","unstructured":"Miller, S. B. M., Mogk, A. & Bukau, B. Spatially organized aggregation of misfolded proteins as cellular stress defense strategy. J. Mol. Biol. 427, 1564\u20131574 (2015).","journal-title":"J. Mol. Biol."},{"key":"7699_CR63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/hsz-2015-0250","volume":"397","author":"S Cappelli","year":"2016","unstructured":"Cappelli, S. et al. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations. Biol. Chem. 397, 401\u2013415 (2016).","journal-title":"Biol. Chem."},{"key":"7699_CR64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324\u2013332 (2011).","journal-title":"Nature"},{"key":"7699_CR65","doi-asserted-by":"crossref","first-page":"e41344","DOI":"10.1371\/journal.pone.0041344","volume":"7","author":"E Kachooei","year":"2012","unstructured":"Kachooei, E. et al. Oligomeric forms of insulin amyloid aggregation disrupt outgrowth and complexity of neuron-like PC12 cells. PLoS ONE 7, e41344 (2012).","journal-title":"PLoS ONE"},{"key":"7699_CR66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0005-2736(97)00265-4","volume":"1370","author":"BS Selinsky","year":"1998","unstructured":"Selinsky, B. S. et al. The aminosterol antibiotic squalamine permeabilizes large unilamellar phospholipid vesicles. Biochim. Biophys. Acta 1370, 218\u2013234 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"7699_CR67","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.1421961112","volume":"112","author":"A Abelein","year":"2015","unstructured":"Abelein, A., Gr\u00e4slund, A. & Danielsson, J. Zinc as chaperone-mimicking agent for retardation of amyloid \u03b2 peptide fibril formation. Proc. Natl Acad. Sci. USA 112, 5407\u20135412 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7699_CR68","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/anie.201409050","volume":"54","author":"FS Ruggeri","year":"2015","unstructured":"Ruggeri, F. S. et al. Influence of the \u03b2-sheet content on the mechanical properties of aggregates during amyloid fibrillization. Angew. Chem. Int. Ed. Engl. 54, 2462\u20132466 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"7699_CR69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acs.biochem.5b01259","volume":"55","author":"J Roche","year":"2016","unstructured":"Roche, J., Shen, Y., Lee, J. H., Ying, J. & Bax, A. Monomeric A\u03b21\u201340 and A\u03b21\u201342 peptides in solution adopt very similar Ramachandran map distributions that closely resemble random coil. Biochemistry 55, 762\u2013775 (2016).","journal-title":"Biochemistry"},{"key":"7699_CR70","doi-asserted-by":"crossref","first-page":"e86720","DOI":"10.1371\/journal.pone.0086720","volume":"9","author":"C Capitini","year":"2014","unstructured":"Capitini, C. et al. TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells. PLoS ONE 9, e86720 (2014).","journal-title":"PLoS ONE"},{"key":"7699_CR71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71\u201394 (1974).","journal-title":"Genetics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07699-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07699-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:05:47Z","timestamp":1671217547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07699-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["7699"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07699-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: M.Z. is one of the inventors in a patent for the use of trodusquemine in the treatment of Parkinson\u2019s disease. C.M.D., M.V., S.I.A.C., T.P.J.K., J.H. and S.L. are co-founders of Wren Therapeutics Limited, which is independently pursuing inhibitors of protein misfolding and aggregation.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}